e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Models of airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Control of mucus hypersecretion by small polycationic peptides
K. C. Kim (Philadelphia, United States Of America)
Source:
Annual Congress 2010 - Models of airways disease
Session:
Models of airways disease
Session type:
E-Communication Session
Number:
3705
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. C. Kim (Philadelphia, United States Of America). Control of mucus hypersecretion by small polycationic peptides. Eur Respir J 2010; 36: Suppl. 54, 3705
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis
Source: Eur Respir J 2004; 24: 958-963
Year: 2004
Club cell 10-kDa protein attenuates airway mucus hypersecretion and inflammation
Source: Eur Respir J 2014; 44: 1002-1010
Year: 2014
Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Mucus secretion by tracheal submucosal glands is induced by relaxing not by stretching
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008
Effect of sildenafil on mucus hypersecretion of rat airway
Source: Eur Respir J 2007; 30: Suppl. 51, 523s
Year: 2007
EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands
Source: Eur Respir J 2001; 18: 176-183
Year: 2001
The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Peptidergic control of mucus secretion studied in human tracheal gland cells
Source: Eur Respir J 2001; 18: Suppl. 33, 77s
Year: 2001
Distribution of vasoactive intestinal peptide( VIP)- and substance P (SP)- containing innervation in bronchi of patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004
Regulation of MUC5AC mucin secretion by depletion of AQP5 in human airway submucosal gland cells
Source: Eur Respir J 2006; 28: Suppl. 50, 756s
Year: 2006
Thrombin stimulates mucin secretion from airway epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 570s
Year: 2002
TLR4 mediates LPS-induced mucus hypersecretion in rat airway
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
Concentration of vasoactive intestinal peptide (VIP) and substance P (SP) in bronchi of patients with mild to moderate bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 583s
Year: 2005
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice
Source: Eur Respir J 2010; 36: 1120-1130
Year: 2010
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps
Source: Eur Respir J 2004; 24 : 594-600
Year: 2004
Genetic influence on chronic mucus hypersecretion – a twin study
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Assessing mucus secretion in murine tracheal explants
Source: Eur Respir J 2002; 20: Suppl. 38, 484s
Year: 2002
Chronic mucus hypersecretion in severe asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept